Scripintelligence - US FDA orders opioid makers to develop doctor education programs

Scrip Clinica Scrip Regulatory Affairs Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

US FDA orders opioid makers to develop doctor education programs
21 April 2011
Donna Young

Please Login to read the full article.

Not a subscriber? Subscribe to Scrip Request a FREE Trial

RELATED CONTENT

NEWS Scrip News

Janssen wins US FDA nod for chronic pain drug Nucynta ER
FDA accepts Endo's harder-to-abuse Opana ER application, with six-month review set
Collegium collects $22M in venture round for tamper-resistant ER oxycodone product
PharmacoFore secures $10M Series B to advance "next generation" abuse resistant opioids, plus propofol alternative

Other Informa News

COMMENT Scrip Comment

Positive vote for Lorqess (and Qnexa) is no guarantee of obe$ity $uccess

Other Informa Comment

Telehealth solutions are showing their value but are still in need of a strategy

FEATURES Other Informa Features

EVENTS

Understanding the basics of EU regulatory affairs

Today

The Rembrandt Hotel, London

Clinical trial regulatory and guideline requirements

07 June 2012

The Rembrandt Hotel, London

16th Annual European PRO & ePRO Congress

12 June 2012

Annecy, France

JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm